Keyphrases
Receptor Binding
100%
Bone Resorption
100%
Decoy Receptor
100%
Receptor Heteromers
100%
Osteoprotegerin
100%
Tumor Necrosis Factor Superfamily
100%
Therapeutic Target
50%
Nuclear factor-B
50%
Metastasis
50%
Receptor Signaling
50%
TNF Receptor 1 (TNFR1)
50%
High Affinity
50%
Pathological Conditions
50%
Genetic Approach
50%
Signaling System
50%
Single Molecule
50%
Polypeptide Chain
50%
Osteoclastogenesis
50%
Osteoporosis
50%
Osteoclast Formation
50%
RANKL-induced Osteoclastogenesis
50%
Binding Interface
50%
Forward Genetics
50%
Ligand-receptor Pairs
50%
In Vitro Resorption
50%
RANKL Protein
50%
Homotrimer
50%
Medicine and Dentistry
Tumor Necrosis Factor
100%
Receptor
100%
Osteoclast Differentiation Factor
100%
Osteoclastogenesis
37%
Osteolysis
25%
Receptor Binding
25%
Osteoprotegerin
25%
Monomer
25%
Cytokine
12%
Tumor Necrosis Factor Receptor
12%
Malignant Neoplasm
12%
In Vitro
12%
Nuclear Factor
12%
Alternative Complement Pathway C3 C5 Convertase
12%
Metastatic Carcinoma
12%
Polypeptide
12%
Disease
12%
Osteoporosis
12%
Biochemistry, Genetics and Molecular Biology
Tumor Necrosis Factor
100%
RANKL
100%
Oligomerization
100%
Osteoclastogenesis
37%
RANK
37%
Osteolysis
25%
Osteoprotegerin
25%
Receptor Binding
25%
Cytokine
12%
Complement Factor B
12%
Tumor Necrosis Factor Receptor
12%
Genetic Approach
12%
Forward Genetics
12%
Homotrimer
12%
Immunology and Microbiology
Tumor Necrosis Factor
100%
RANKL
100%
Oligomerization
100%
Osteoclastogenesis
37%
RANK
37%
Receptor Binding
25%
Osteolysis
25%
Osteoprotegerin
25%
Cytokine
12%
Complement Factor B
12%
Tumor Necrosis Factor Receptor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Receptor
100%
Osteoclast Differentiation Factor
100%
Monomer
25%
Osteoprotegerin
25%
Malignant Neoplasm
12%
Cytokine
12%
Alternative Complement Pathway C3 C5 Convertase
12%
Nuclear Factor
12%
Polypeptide
12%
Tumor Necrosis Factor Receptor
12%